Charles Schwab’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.55M | Sell |
|
|||||
|
2025
Q2 | $608K | Buy |
|
|||||
|
2025
Q1 | $798K | Hold |
|
|||||
|
2024
Q4 | $1.22M | Sell |
|
|||||
|
2024
Q3 | $916K | Hold |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $155K | Hold |
|
|||||
|
2023
Q4 | $173K | Hold |
|
|||||
|
2023
Q3 | $56.8K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $318K | Buy |
|
|||||
|
2022
Q4 | $1.23M | Buy |
|
|||||
|
2022
Q3 | $1.14M | Buy |
|
|||||
|
2022
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q1 | $707K | Buy |
|
|||||
|
2021
Q4 | $404K | Buy |
|
|||||
|
2021
Q3 | $821K | Sell |
|
|||||
|
2021
Q2 | $4.03M | Buy |
|
|||||
|
2021
Q1 | $5.22M | Buy |
|
|||||
|
2020
Q4 | $4.71M | Buy |
|
|||||
|
2020
Q3 | $6.62M | Buy |
|
|||||
|
2020
Q2 | $8.68M | Sell |
|
|||||
|
2020
Q1 | $5.79M | Sell |
|
|||||
|
2019
Q4 | $13.2M | Sell |
|
|||||
|
2019
Q3 | $8.82M | Buy |
|
|||||
|
2019
Q2 | $8.76M | Buy |
|
|||||
|
2019
Q1 | $5.5M | Buy |
|
|||||
|
2018
Q4 | $6.07M | Sell |
|
|||||
|
2018
Q3 | $5.97M | Buy |
|
|||||
|
2018
Q2 | $4.37M | Buy |
|
|||||
|
2018
Q1 | $6.9M | Buy |
|
|||||
|
2017
Q4 | $5.99M | Sell |
|
|||||
|
2017
Q3 | $4.6M | Buy |
|
|||||
|
2017
Q2 | $3.16M | Buy |
|
|||||
|
2017
Q1 | $1.95M | Buy |
|
|||||
|
2016
Q4 | $572K | Buy |
|
|||||
|
2016
Q3 | $331K | Sell |
|
|||||
|
2016
Q2 | $410K | Sell |
|
|||||
|
2016
Q1 | $788K | Buy |
|
|||||
|
2015
Q4 | $1.01M | Buy |
|
|||||
|
2015
Q3 | $1.04M | Buy |
|
|||||
|
2015
Q2 | $1.84M | Buy |
|
|||||
|
2015
Q1 | $852K | Buy |
|
|||||
|
2014
Q4 | $288K | Buy |
|